Abstract

Bats host a number of viruses that cause severe disease in humans without experiencing overt symptoms of disease themselves. While the mechanisms underlying this ability to avoid sickness are not known, deep sequencing studies of bat genomes have uncovered genetic adaptations that may have functional importance in the antiviral response of these animals. Egyptian rousette bats (Rousettus aegyptiacus) are the natural reservoir hosts of Marburg virus (MARV). In contrast to humans, these bats do not become sick when infected with MARV. A striking difference to the human genome is that Egyptian rousettes have an expanded repertoire of IFNW genes. To probe the biological implications of this expansion, we synthesized IFN-ω4 and IFN-ω9 proteins and tested their antiviral activity in Egyptian rousette cells. Both IFN-ω4 and IFN-ω9 showed antiviral activity against RNA viruses, including MARV, with IFN-ω9 being more efficient than IFN-ω4. Using RNA-Seq, we examined the transcriptional response induced by each protein. Although the sets of genes induced by the two IFNs were largely overlapping, IFN-ω9 induced a more rapid and intense response than did IFN-ω4. About 13% of genes induced by IFN-ω treatment are not found in the Interferome or other ISG databases, indicating that they may be uniquely IFN-responsive in this bat.

Highlights

  • Bats comprise about 20% of all classified mammal species with over 1,200 species and host a number of viruses known to cause severe disease in humans

  • We have previously shown that the type I IFN locus is expanded in the Egyptian rousette (R. aegyptiacus), an asymptomatic host of Marburg virus (MARV) [19]

  • We annotated the broad collection of residues that participate in receptor binding on all 22 proteins using the NCBI conserved domain database search

Read more

Summary

Introduction

Bats comprise about 20% of all classified mammal species with over 1,200 species and host a number of viruses known to cause severe disease in humans. While humans develop severe and life-threatening illnesses from many of these viruses (e.g., henipaviruses, SARS and MERS coronaviruses, and filoviruses), bats show no symptoms of disease in natural or experimental infections [1, 2]. Type I IFNs are induced by the recognition of viral pathogen-associated molecular patterns (PAMPs), and act by inducing interferon stimulated genes (ISGs) that collectively contribute to Cellular Response to Bat INF-ω an antiviral response [4, 5]. The exact functional contribution for each IFN is not completely understood, differences in the interaction of various IFN subtypes with IFNAR1/2 are known to differentially induce downstream ISGs [10,11,12]. Differences in pathogen-specific antiviral effect are possible, depending on the amount and profile of ISGs induced by a particular IFN

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call